the science of healthier animals - 5m...

THE SCIENCE of HEalTHIEr aNImalS

2 The science of healThier animals

3

BECauSE aNImal HEalTH IS our HEalTH

At Merck Animal Health we’ve begun a new chapter. It’s a chapter being written to meet the demands of a world changing in more ways than we could have imagined.

Every day our customers and partners face challenges that are wider, more complex and developing faster than ever. Not least how animal health is now so tied to our own.

Today, ThE sciENcE of hEalThiEr aNimals is also the science of food safety and supply, of international public health. it’s the science of keeping people happy by protecting and caring for their family pets.

meat and dairy consumption for example, is at the heart of changing lifestyles around the globe. as asian and latin-american economies continue to flourish, so does the appetite for protein-rich diets. a 50% increase in demand for animal protein is expected in the next 10 years. so we must keep developing vital vaccines like Porcilis PcV for swine, and pharmaceuticals like NUflor for cattle, to help producers fight diseases that devastate production.

Keeping our protein supplies plentiful also means investing in sustainable business. Programs like our slicE sustainability Project which, developed in close partnership with fish farmers, helps control parasites more sustainably and keeps animal health products effective. in turn it improves the efficiency and long-term value of fish production.

We know too that global trade, migrating people and climate change may increase the spread of highly infectious diseases like foot-and-mouth disease, and zoonotic diseases like avian flu. only a fast, flexible approach to vaccination will stop them. NoBilis salenvac T and NoBilis influenza are just two of the vaccines helping us control the spread of pathogens into our food supplies and communities.

finally, we will strive to protect and prolong our relationships with the pets at the heart of our families. We’re investing in medicines for age-related diseases – like us, pets are living longer – as well as in healthier, more effective ways to approach parasites with treatments like acTiVYl.

Whatever we do to evolve our health platforms in the future, one thing is clear: No business, no government can meet these challenges alone. Today we stand in full knowledge that to succeed we need the joint effort, expertise and insight of all of our stakeholders, customers and partners.

so while our commitment to scientific progress continues, so does our understanding of what that progress means to our customers in the real world. as the people behind ThE sciENcE of hEalThiEr aNimals, we know we must also understand the science of running a business, of feeding a nation, of maintaining healthier populations. as such, we’ll make sure we have the products, technologies, services and insight to tackle our customers’ commercial, operational and governmental demands.

We’ll put every inch of our experience, resources, and pioneering spirit behind them.

We will be driven by their challenges. Their prosperity will be ours.

Richard R. DeLuca Jr. President, Merck Animal Health

January 2012

5

a purpoSE drIvEN parTNErSHIp

our CuSTomErS HavE alwayS ExpECTEd morE from uS THaN juST mEdICINES. So, from THE fIrST dayS of our CompaNy, mErCk aNImal HEalTH HaS STrIvEN To dEvElop THE INformaTIoN, TECHNologIES aNd vETErINary SErvICES THaT makE aNImal HEalTHCarE a rICHEr, morE INNovaTIvE SECTor for uS all.

sharing information is one of the best ways we can help customers better manage and care for their animals. in 1955 merck published the first edition of the now world-famous merck Veterinary manual. Ever since, our practice of sharing knowledge and expertise has lived on.

Global animal management is the part of our company that develops innovative technologies to help producers identify, monitor and sell their livestock. With our Tri-mEriT program for cattle, we’re helping them maximize the health and value of their animals.

integrating products and emerging technologies is more efficient and cost-effective for our partners. our dedicated swine health service rEsPiG, for example, provides cutting-edge insights into complex respiratory diseases, vaccines and ways to limit stock losses.

most importantly our holistic approach is embedded right into how each arm of our company operates. animal diseases rarely occur in isolation. in poultry for example, respiratory problems are often complicated by a whole host of other factors – like their vaccination schedule. Eradicating disease takes a carefully crafted program that tackles them all.

so, at merck animal health, our veterinarians, scientists and business experts work together in teams centered around significant categories of disease, not just single products. it means they’re free to dive deep into what really influences the spread and virulence of pathogens. This cross-fertilization across research areas helps us accelerate the development of complete animal health solutions.


When Merck and Schering-Plough merged in 2009, we became a division of the second-largest health company in the world.

The animal health expertise of our three original companies; merck, intervet and schering-Plough animal health, dates back at least 60 years. The establishment of each was sparked by breakthrough ideas – ideas from people with the intelligence and spirit to take on the diseases they saw harming the animals, people and livelihoods around them.

Merck in the 1930s merck scientists in the Us were seeking a drug for human streptococcal infection. instead they found sulfaquinoxaline, which proved to be a highly effective treatment for coccidiosis in chickens. merck wasted no time turning it into a drug, and started a soon to be successful animal health division.

Intervet it was feed manufacturer Wim hendrix who laid the foundations of intervet in 1949 in the Netherlands. he observed that ‘sick chickens don’t eat’, and set about enlisting scientists to create the first ever vaccine for fowl Pox. it was one of many firsts intervet was to bring to the animal health market.

our STory So far

1970sIntroductIon of

antI-Inflammatory BanamInE/fInadynE

(flunIxIn mEglumInE) for horsEslaunch of products for

rEproductIon managEmEnt In farm anImals

dEvElopmEnt of anthElmIntIc fEnBEndazolE, latEr markEtEd

as panacur/safE-guard

1940dIscovEry of

sulfaquInoxalInE, thE fIrst poultry

coccIdIostat

1955fIrst EdItIon of

thE mErck vEtErInary manual

1949fIrst fowl pox vaccInE

1949dEvElopmEnt of

prEdnIsonE to trEat kEtosIs In

daIry cattlE

mErCk aNImal HEalTH HaS a rICH, INNovaTIvE paST. Now our ExpErIENCE IS HElpINg uS SHapE THE fuTurE. So wHIlE wE CHErISH our BEgINNINgS, wE alSo kNow wE arE morE THaN a Sum of our parTS. Today wE’rE STrIvINg To BEComE aN EvEN morE amBITIouS, INNovaTIvE forCE for progrESS IN SCIENCE.

7

Schering-Plough Animal Health schering-Plough’s animal health division was formally established in 1955 in the Us. it was created to supply demand for the corticosteroid prednisone (originally a human drug), to fight ketosis in dairy cattle. The original sales team of three, grew ten-fold in two years, and went on to establish a leading position in the animal health market.

2009dEvElopmEnt of sphErEon frEEzE-dryIng tEchnology

for vaccInEs

2011launchEd zuprEvo for

thE trEatmEnt of BovInE rEspIratory dIsEasE

1990sdEvElopmEnt of florfEnIcol, a novEl phEnIcol antIBIotIc ExclusIvE to anImal hEalth

IntroductIon of antIparIsItIc scalIBor (dEltamEthrIn) and Ear InfEctIon drug otomax

(gEntamIncIn/BEtamEthasonE/clotrImazolE) for dogs

1980sdEvElopmEnt of IvErmEctIn, onE of thE most succEssful

vEtErInary drugs EvErfIrst rEcomBInant dna vaccInE

(porcIlIs porcolI agaInst dIarrhEa In pIglEts)

2000sslIcE (EmamEctIn) fIsh

antIparasItIc Is launchEd for thE trEatmEnt of sEa lIcE

In salmonlIcEnsEd thE fIrst lIvE BactErIal rEcomBInant vaccInE agaInst stranglEs In horsEs In thE EuIntroductIon of porcIlIs pEstI, thE fIrst markEr vaccInE for

classIcal swInE fEvEr

oNE of THE moST rECENT ExTENSIoNS of our CapaBIlITIES IS THE SpHErEoN maNufaCTurINg faCIlITy IN THE NETHErlaNdS. our uNIquE paTENTEd TECHNology frEEzE-drIES lIvE poulTry vaCCINES INTo Small, HIgHly-SoluBlE SpHErES THaT arE EaSIEr To admINISTEr.

SpoTlIgHT oN our lEadErSHIp


THE SCIENCE NEvEr STopS

70-80% of our produCT pIpElINE rEaCHES THE markET. THE INduSTry-lEadINg BrEakTHrougHS our CuSTomErS ExpECT from uS rEquIrE THE BEST SCIENTISTS, aNd THE BEST faCIlITIES IN THE world.

With a worldwide network of dedicated pharmaceutical and vaccine r&D and manufacturing sites, merck animal health is better adapted to provide local solutions to our partners, helping them tackle both global and regional diseases.

• Severaldedicatedworld-classpharmaceuticalresearchsites and multi-species r&D centers of excellence for vaccines

• Morethan100ongoingpharmaceuticalR&Dprojects(focused on anti-parasitics, anti-infectives, endocrine drugs and pain medicine)

• Morethan100ongoingbiologicalR&Dprojects(focused on zoonotic, respiratory, enteric and emerging diseases and enabling technologies)

• Globalmanufacturingnetwork

Nevertheless, the pace of scientific innovation today means no company can afford to work in isolation. We combine our in-house r&D expertise with an active business development and in-licensing program, and constantly partner with specialist biotechnology companies, universities and research institutions.

Working closely with our human health colleagues also helps us exploit the strength of our combined science base. our PosaTEX eardrops, for the treatment of otitis externa in dogs, was originally developed as asmaNEX to treat asthma in humans. our antifungal drug posaconazole was first marketed as NoXafil for prophylaxis and treatment of fungal infections for people.


qualITy proTEIN for a HEalTHy world

By 2050 IT IS ESTImaTEd THErE wIll BE aN ExTra 2 BIllIoN pEoplE IN THE world. To fEEd THEm, wE wIll NEEd To HElp aNImal produCErS BEComE morE EffICIENT aNd morE SuSTaINaBlE.

animal diseases still cost farmers a significant proportion of their meat, fish and dairy yield. Preventing disease-related costs will be crucial if we are to meet the demand for protein, created by rising standards of living and population growth. in addition, the land and water available for agriculture will only decrease. so not only will our animals have to be healthier, they will have to be reared more efficiently too.

our portfolio is already focused on helping farmers keep their livestock productive. Targeted intervention with vaccines, therapeutics and performance technologies

ensures that animals reach their full weight in good health.

our global reach also means few companies are better placed to limit production losses from epidemics. To tackle foot-and-mouth disease for example, merck animal health has the resources, including antigen banks managed on behalf of governments, to better prevent and manage outbreaks across international borders.

12

mErCk aNImal HEalTH IS dEvElopINg TECHNologIES THaT HElp maxImIzE opEraTIoNal EffICIENCy. TECHNologIES lIkE TrI-mErIT – a SImplE Ear Tag SySTEm THaT dIgITally vErIfIES agE, SourCE aNd movEmENT of aNImalS. IT’S aNoTHEr way THaT mErCk aNImal HEalTH IS HElpINg farmErS To INCrEaSE THEIr produCTIoN CapaBIlITIES.

SpoTlIgHT oN dIgITal CowS

The science of healThier animals

13

rumINaNTS

The lives of millions of people around the world depend on the health of their cattle, sheep and goat herds. But with fewer natural resources, and changes in our climate, we must rear them more efficiently, and continue to eradicate diseases that lower meat and milk yields.

our portfolio for ruminants is organized into eight specific health platforms. Provided under the umbrella name EXPErTis, our products and services have been developed to work together around our customers’ greatest needs. our health platforms are:

• HerdHealth

• LungHealth

• NeonatalHealth

• ParasiteControl

• PartnersinReproduction

• PerformanceTechnology

• SheepHealth

• UdderHealth

Tackling the world’s most virulent infectious diseases is the first step in ensuring reliable meat and milk supplies. collaboration with veterinarians, farmers, regulators and scientists has helped us implement herd health programs in many regions of the world. BoVilis BVD, for control of bovine viral diarrhea, is now one of the most important vaccines for dairy cattle in Europe. BoVilis BTV8 was developed in less than two years, in rapid response to the spread of the bluetongue virus across Europe in 2007.

controlling parasites is also vital to help farmers ensure maximum productivity. our parasite control platform includes a full range of worm and fluke control products, including the anthelmintic PaNacUr/safE-GUarD (fenbendazole) and the antiprotozal drug halocUr (halofuginone lactate).

our lung health platform provides customers with tailor-made programs to tackle complex problems like bovine respiratory disease. it also includes antibiotics like NUflor (florfenicol) and rEsflor (florfenicol plus flunixin). and vaccines that guard against infectious bovine rhinotracheitis (iBr) and parainfluenza-3 (Pi3).

Products that improve performance are key to efficient, sustainable production. Products like ZilmaX (zilpaterol), ralGro (zeranol) and rEValor (trenbolone/estradiol) are proven to improve feed conversion and aid weight gain.


increasing meat supplies relies on a more intensive, large-scale approach to farming. larger animal groups need to be carefully protected from disease. Ecological upheavals, and the migration of parasites and wild animals, can all encourage the spread of zoonoses – which is a particular threat for our swine farmers.

To help them control the swine influenza virus (siV) we have developed maXiVac Excel 5.0. it is the first pentavalent inactivated vaccine to control most common strains of swine influenza.

similarly, in the fight against Escherichia coli, merck animal health offers producers Porcilis Porcoli Df.

other important swine vaccines include Porcilis PcV and circUmVENT PcV/mhyo which prevent the spread of porcine circovirus type 2, a cause of growth retardation in swine. Porcilis Prrs provides protection against the virus responsible for porcine reproductive and respiratory syndrome, and Porcilis aPP, a subunit vaccine, reduces pulmonary lesions caused by Actinobacillus pleuropneumoniae infection.

apart from vaccines, the swine pharmaceutical range includes the antibiotics NUflor (florfenicol), coBacTaN (cefquinome) and ZUPrEVo (tildipirosin) as well as PaNacUr aquasol (fenbendazole), a potent antiparasitic.

our new iDal vaccinator, which allows needleless intradermal administration, will make vaccination easier and more efficient for swine producers.

SwINE

15

SpoTlIgHT oN parTNErSHIp

aT mErCk aNImal HEalTH wE BElIEvE CollaBoraTIoN IS a BETTEr way To TaCklE CHallENgINg dISEaSES. rESpIg, for ExamplE, IS our dEdICaTEd SwINE HEalTH SErvICE for vETErINarIaNS, produCErS aNd our oTHEr SpECIalIST parTNErS. IT CoNTaINS CuTTINg-EdgE INSIgHTS oN maNy ComplEx rESpIraTory dISEaSES, aNd makES IT EaSy for EvEryoNE To CoNTrIBuTE To SoluTIoNS.


SpoTlIgHT oN CHICkENS.Com

ComprEHENSIvE wEBSITES CovErINg INTESTINal HEalTH (www.IHC-poulTry.Com), gumBoro dISEaSE (www.gumBoro.Com) aNd INfECTIouS BroNCHITIS (www.INfECTIouS-BroNCHITIS.Com) kEEp farmErS, vETErINarIaNS, NuTrITIoNISTS aNd aCadEmICS updaTEd oN THE laTEST BrEakTHrougHS IN mEdICaTIoN, SaNITaTIoN aNd NuTrITIoN.

17

meeting consumer demand is the key to success for our poultry customers. like the demand for impeccable food safety.

salmonella is one of the most common food-borne, disease-causing bacteria, and can cause severe gastroenteritis in humans. our food safety Platform combines vaccines like NoBilis salenvac T (the broadest spectrum salmonella vaccine available) with services that ensure effective, timely intervention. These include the Pin-Point monitoring Program for poultry operations, helping producers identify critical food safety hazard points.

as well as food safety we’ve also developed platforms for intestinal health, respiratory Protection and Dynamic immunity.

Good intestinal health is vital for birds to convert their feed properly, and gain sufficient weight. our intestinal health Platform is made up of market-leading vaccines like cocciVac and ParacoX – offering protection against coccidiosis and necrotic enteritis.

The iNNoVaX range is the cornerstone of our respiratory Protection Platform. it includes live virus vector vaccines, offering protection against marek’s disease, Newcastle disease (ND) and infectious laryngotracheitis (ilT).

our ProTEcToTYPE approach to vaccination is a uniquely effective way to tackle respiratory infections like bronchitis. combining live vaccines such as NoBilis iB ma5, iB 4/91 and inactivated ones like NoBilis iB multi, gives optimal protection against the strain range. The vaccination schedule is tailored to local requirements, epidemiological situation and the type of production.

strong pillars of our Dynamic immunity Platform are our live infectious bursal disease virus (iBDV) vaccines, protecting birds against Gumboro disease. NoBilis D78 and NoBilis 228E live vaccines set the standard for iBD protection around the world.

poulTry


aquaTIC aNImalS

Demand for fish protein is rising. farmed fish is becoming more important to meet this demand and protect wild fish. currently half of all fish consumed globally is farmed. at merck animal health we must help forge a sustainable, environmentally conscious future for this aquaculture.

Protecting fish from disease, and controlling bacteria and parasites is vital to ensure consistent, sustainable harvests. all our vaccines aid stock replenishment by allowing fish to better convert feed, grow bigger and stay healthy.

our major lines of vaccines, NorVaX and aQUaVac, have been developed to fight a huge range of infectious diseases in salmon, trout, sea bass, bream, tilapia and many others.

The re-emergence of pancreatic disease (PD) in salmon has also created a vital role for products like NorVaX compact PD. aQUaVac iPN is our innovative oral vaccine for control of infectious pancreatic necrosis (iPN).

Bacterial diseases can also be controlled through the in-feed antibiotic aQUaflor (florfenicol).

19

SpoTlIgHT oN SlICE

THE uNIquE SlICE SuSTaINaBIlITy projECT IS kEEpINg SEa lICE uNdEr CoNTrol wHIlE HElpINg To maxImIzE TrEaTmENT ouTComES aNd rEduCE dEvElopmENT of rESISTaNCE.


Innovax vaccInEs arE strEngthEnIng thE

north and latIn-amErIcan poultry markEt agaInst

InfEctIous laryngotrachEItIs, marEk’s dIsEasE and nEwcastlE dIsEasE.

wE producE somE of our foot-and-mouth dIsEasE

vaccInEs for rumInants locally, for ExamplE In IndIa and BrazIl, mEEtIng local nEEds for spEcIfIc

straIns of thE vIrus.

gloBal SCopE, loCal ImpaCT

BovIlIs Bvd for BovInE vIral dIarrhEa Is onE of

EuropE’s most Important cattlE vaccInEs.

aquaflor (florfEnIcol) Is thE fIrst

nEw In-fEEd antIBIotIc for us aquaculturE In 20 yEars. It controls

morBIdIty and mortalIty In frEsh-watEr salmonIds.

21

to control thE rEcEnt outBrEak of foot-and-mouth dIsEasE In south korEa wE provIdEd half

of thE country’s vaccInEs (12 mIllIon dosEs).

mErCk aNImal HEalTH’S gloBal CommErCIal NETwork CovErS ovEr 140 CouNTrIES. wE’vE aCHIEvEd our rEaCH THrougH aN aBSoluTE CommITmENT To rEgIoNal uNdErSTaNdINg. IT HElpS uS rEaCT quICkly To CHaNgINg dISEaSE laNdSCapES arouNd THE world.

porcIlIs BEgonIa, thE fIrst approvEd markEr vaccInE In EuropE, has sold

ovEr 700 mIllIon dosEs.

pIlIguard pInkEyE-1

trIvalEnt vaccInE Is protEctIng australIa agaInst pInkEyE,

Its most ExpEnsIvE BovInE dIsEasE.


CrEaTINg CompaNIoNSHIp THaT laSTS

SpoTlIgHT oN HomEagaIN

5.2 mIllIoN pETS IN THE uSa HavE BEEN ENrollEd IN our HomEagaIN mICroCHIp-BaSEd pET rECovEry program, rESulTINg IN morE THaN 1 mIllIoN SuCCESSful rECovErIES So far. IT’S juST oNE way wE uSE our parTNEr NETwork To HElp aNImalS arouNd THE world.

23

merck animal health is one of the few companies with the manufacturing capabilities to help veterinarians meet this rapid rise in demand for pet healthcare products.

our vaccine portfolio for dogs and cats is led by the NoBiVac range. The canine parvo virus (cPV) strain c154 in our NoBiVac DhPPi dog vaccine means it is the first low-passage/high titer vaccine that can break through maternally-derived antibodies against cPV effectively.

in response to a call from the american Veterinary medical association (aVma), we have also developed the first vaccine against canine influenza, NoBiVac canine flu h3N8.

cats are protected against feline panleukopenia virus, feline herpes virus and feline calicvirus by NoBiVac Tricat Trio. similarly, NoViBac myxo-rhD is a live chimera rabbit vaccine that protects against myxomatosis and rabbit hemorrhagic disease (rhD) with a single injection.

as more people keep pets, it’s important we do more to control the spread of parasites in the home. along with PaNacUr/safE-GUarD (fenbendazole) and TrihEarT PlUs (ivermectin plus pyrantel), a canine heartworm preventative, the scaliBor Protector Band (deltamethrin) protects dogs against leishmaniasis. leishmaniasis is one of the world’s most deadly parasitic diseases and is linked to 60,000 human deaths annually.

as our bond with our pets becomes stronger, we want to make sure treatments are as gentle on them as they are effective. acTiVYl (indoxacarb) and acTiVYl TickPlus (indoxacarb plus permethrin) are new and unique flea products that use ‘bioactivation’. acTiVYl minimizes pet exposure to chemicals, because it only becomes active inside the flea.

We know too that pets are now living longer. our portfolio has grown to match them. caNiNsUliN (porcine insulin zinc suspension) helps dogs and cats with diabetes mellitus, and ViDalTa (carbimazole) is our prolonged-release tablet for easy oral treatment of feline hyperthyroidism.

THE grEaT SHIfTS IN gloBal wEalTH mEaN maNy morE pEoplE Now HavE THE TImE aNd moNEy THEy NEEd To kEEp pETS IN THE HomE. aNd mErCk aNImal HEalTH IS HElpINg THEm look afTEr THEIr HEalTH aNd wEllBEINg.


HorSES

Breeding and caring for horses is a complex and often expensive business. To maximize the value of their stock and the wellbeing of their animals, our customers need the best equine healthcare.

in response, merck animal health has grown to become market leader in equine vaccines, protecting horses against both established and newly emerging diseases.

Equine influenza continues to be the most common viral respiratory disease found in horses. one of the most effective treatments is merck animal health’s EQUilis Prequenza vaccine. it provides active, annual immunization against equine influenza and tetanus.

strangles remains a common and deadly equine disease, caused by the Streptococcus equi bacteria. EQUilis strepE helps veterinarians dramatically reduce clinical signs and prevent lymph node abscessation.

as well as our vaccines, we help keep horses healthy with a range of leading pharmaceuticals. The anti-infective coBacTaN (cefquinome) is licensed for the treatment of foal septicemia and equine respiratory disease and can be administered intravenously or intramuscularly.

managing colic is a common concern for all horse breeders and owners. Prescribing DolorEX (butorphanol), an analgesic, helps veterinarians both relieve pain and sedate the horse.

25

THE TradE aNd movEmENT of HorSES IS aN ESSENTIal aNd valuaBlE parT of HorSE BrEEdINg. wE CaN HElp BrEEdErS proTECT THIS parT of THEIr BuSINESS wITH EmErgINg TECHNologIES lIkE eyed. eyed IS THE world’S fIrST EquINE IrIS SCaNNINg CamEra. HorSES’ IrISES arE morE uNIquE THaN a fINgErprINT, So THE eyed CamEra aNd oNlINE daTa SToragE program form THE moST prECISE, SECurE EquINE IdENTIfICaTIoN SySTEm avaIlaBlE.

SpoTlIgHT oN eyed


fErTIlITy IS fuNdamENTal

27

EradICaTINg dISEaSE proTECTS our food SupplIES. BuT good fErTIlITy IS vITal Too. mErCk aNImal HEalTH’S fErTIlITy programS ENSurE CoNSISTENT, HEalTHy BrEEdINg aNd SafEguard SupplIES of proTEIN To THE world’S mEaT markETS.

more meat and dairy in our diets increases pressure on producers to keep breeding levels high and predictable. merck animal health’s fertility programs for production animals have several integral elements:

• Hormonesthatsynchronizereproductioncycles

• Productsthatfacilitateinseminationandoptimizebreeding strategies like embryo transfer

• Vaccinesthatprotectagainstinfectionsthataffectfertility and could pose a threat to human health

• Toolsthathelpdiagnoseandtreatuterineinfections in cattle

for cattle, our hormone portfolio includes rEcEPTal (buserelin), and EsTrUmaTE (cloprostenol). for swine, PG 600 (combination of gonadotropins) promotes a more fertile estrous cycle, and rEGUmaTE (altrenogest), is an oral treatment used in large farms to optimize the breeding process.

our hormones are administered in parallel with vaccinations against diseases that damage reproduction. BoVilis BVD for example, successfully protects cattle from abortions caused by bovine viral diarrhea virus. similarly, oVilis Toxovax and oVilis Enzovax can prevent abortions caused by toxoplasmosis and chlamydophilosis in sheep and goats.

To reduce the movement of animals between farms, and the spread of undetected disease, artificial insemination is important to producers. merck animal health also helps them build a stronger genetic pool with tools for more efficient artificial insemination.

managing reproduction in horses is a complex process that requires expert knowledge. our fertility products help professional stud farms and private individuals optimize their breeding programs.

28

lookINg afTEr Tomorrow

The science of healThier animals

29

Fighting rabies Today, rabies can be controlled through immunization. Which is why we believe every country in the world should be free of this fatal disease. Each year merck animal health donates over 200,000 doses of rabies vaccine to the afya serengeti Project. By tackling rabies in Tanzania’s domestic dog population, we’ve helped dramatically reduce dog bites, and helped protect the country’s fragile wild dog population. in india we sponsor two similar pilot projects in the villages surrounding Bangalore and Pune.

Milk for Malawi Through our partnership with the shire highlands milk Producers association (shmPa), merck animal health lends financial and in-kind support to malawian dairy smallholders. By providing funds, equipment and medicines we’re helping farmers improve the quantity and quality of milk supplies.

Homing Horses in recent years, the Us has seen an increase in its number of unwanted horses. With no national fund in place, merck animal health and the american association of Equine Practitioners (aaEP) have created the Unwanted horse Veterinary relief campaign. We donate thousands of doses of vaccines to rescue homes – helping them look after as many animals as possible.

Reducing Animals in Research To develop life-saving medicines we believe laboratory animal research remains indispensable. But we are dedicated to approaches that reduce the use of animals in science. We award the Dieter lütticken award to researchers who have discovered ways to replace animal testing.

ENSurINg THE SafETy aNd SuSTaINaBIlITy of aNImal SToCkS BENEfITS EvEryoNE. BuT mErCk aNImal HEalTH SomETImES HaS THE opporTuNITy To ImprovE aNImal aNd HumaN wElfarE IN oTHEr wayS.


STarT a HEalTHy parTNErSHIp Today

31

We use our understanding to create health platforms with the power to turn the tide of global diseases, to protect the well-being of our pets, and to help customers take their businesses further.

Partnerships are how we generate truly useful, innovative products. so we’re always ready to begin a new one. if you think merck animal health could help shape the growth and productivity of your business, please contact us.

our produCTS arE SuCCESSful BECauSE THEy arE CrEaTEd THrougH INTuITIvE, CollaBoraTIvE rElaTIoNSHIpS wITH our CuSTomErS. wE work wITH EaCH of our parTNErS To uNdErSTaNd ExaCTly How THEIr BuSINESSES work aNd THEIr parTICular HEalTH CHallENgES.

merck animal health Global communications animal health Po Box 31 5830 aa, Boxmeer The Netherlands

P: +31 485 587600 f: +31 485 577333 E: [email protected] i: www.merck-animal-health.com T: merckah

About Merck Animal Health

Today merck is a global healthcare leader working to help the world be well. merck animal health, known as msD animal health outside the United states and canada, is the global animal health business unit of merck. merck animal health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services. merck animal health is dedicated to preserving and improving the health, well-being and performance of animals. it invests extensively in dynamic and comprehensive r&D resources and a modern, global supply chain. merck animal health is present in more than 50 countries, while its products are available in some 150 markets. for more information, visit www.merck-animal-health.com.

Disclaimer

mErcK and msD are trademarks of merck, sharpe & Dohme corp., a subsidiary of merck & co., inc., Whitehouse station NJ, Usa.

Brand names used in this brochure are trademarks of intervet international B.V. or affiliated companies or licensors and are protected by copyrights, trademark and other intellectual property laws. copyright © 2012 intervet international B.V., a subsidiary of merck & co., inc., Whitehouse station, NJ, Usa. all rights reserved. This document contains information on veterinary products based on international registration dossiers and may refer to products that are either not available in your country or are marketed under a different trade name. in addition, the approved indications as well as safety and efficacy data for a specific product may be different depending on local regulations and approvals. for more information, read the product labeling that applies to your country or contact your local merck animal health/msD animal health representative.

The salmon picture used on pages 18 & 19 is courtesy of marine harvest.

0612

69.0

1.20

12 m

erck

aH ©

201

2, In

terv

et In

tern

atio

nal B

.v. a

sub

sidi

ary

of m

erck

& C

o., I

nc.,

whi

teho

use

Stat

ion,

Nj,

uSa

. all

right

s re

serv

ed.

the science of healthier animals - 5m...

Documents